ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,367Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 403

$926K Total Retail Price of All Prescriptions

Rank: 9 out of 403

352 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 352 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 352 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 8,902 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 544 384 1 2
LISINOPRIL 519 343 2 1
METOPROLOL TARTRATE 429 323 3 10
LEVOTHYROXINE SODIUM 394 294 4 3
TRAZODONE HCL 358 245 5 25
FUROSEMIDE 318 228 6 7
METFORMIN HCL 301 198 7 8
ATORVASTATIN CALCIUM 274 215 8 5
AMLODIPINE BESYLATE 268 192 9 4
HYDROCODONE-ACETAMINOPHEN 241 177 S3 10 15
LANTUS 227 144 11 54
ZOLPIDEM TARTRATE 216 147 12 16
OMEPRAZOLE 208 112 13 9
RISPERIDONE 203 134 14 48
WARFARIN SODIUM 193 130 15 12
GABAPENTIN 191 105 16 17
CYMBALTA 185 113 17 43
DIVALPROEX SODIUM 172 65 18 64
OLANZAPINE 171 128 19 77
CITALOPRAM HBR 165 99 20 22
MIRTAZAPINE 151 117 21 38
SERTRALINE HCL 140 119 22 20
DIVALPROEX SODIUM ER 138 77 23 152
QUETIAPINE FUMARATE 130 50 24 52
BENZTROPINE MESYLATE 119 57 R 25 143
METOPROLOL SUCCINATE 113 102 26 11
CHLORTHALIDONE 112 90 27 84
BACLOFEN 110 49 28 110
FLUOXETINE HCL 104 41 29 57
LEVETIRACETAM 101 19 30 118
ESCITALOPRAM OXALATE 101 76 30 36
NEXIUM 98 78 32 18
HYDROCHLOROTHIAZIDE 98 66 32 6
TOPIRAMATE 97 18 34 125
ATENOLOL 95 59 35 13
DONEPEZIL HCL 95 74 35 23
POTASSIUM CHLORIDE 90 35 37 37
TAMSULOSIN HCL 86 67 38 27
ALLOPURINOL 81 68 39 31
ADVAIR DISKUS 79 44 40 33
CRESTOR 78 48 41 19
CLOZAPINE 77 0 42 128
PRAVASTATIN SODIUM 74 55 43 14
CARBIDOPA-LEVODOPA 74 50 43 78
TRAMADOL HCL 72 60 45 28
SPIRIVA 70 55 46 35
KLOR-CON M20 67 47 47 85
CLOPIDOGREL 66 63 48 55
CEPHALEXIN 64 35 49 133
NAMENDA 62 60 50 41
LOSARTAN POTASSIUM 61 51 51 21
AMITRIPTYLINE HCL 60 13 R 52 131
AZITHROMYCIN 60 47 52 49
HUMALOG 59 25 54 151
PREDNISONE 59 25 54 34
PLAVIX 56 55 56 83
OXYCODONE-ACETAMINOPHEN 56 48 S2 56 45
LIPITOR 56 41 56 53
OXCARBAZEPINE 55 24 59 248
LAMOTRIGINE 54 36 60 168
DIOVAN 53 42 61 24
NOVOLOG 53 28 61 117
CYCLOBENZAPRINE HCL 53 14 R 61 91
ABILIFY 53 23 61 134
PANTOPRAZOLE SODIUM 52 40 65 30
POLYETHYLENE GLYCOL 3350 50 26 66 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.